11 results
424B4
BGLC
BioNexus Gene Lab Corp
21 Jul 23
Prospectus supplement with pricing info
3:37pm
retrial on the merits. The rights of shareholders to take legal action against us and BioNexus’ directors, actions by minority shareholders
10-K
z802k
31 Mar 20
Annual report
1:12pm
S-1/A
7gmygdrjjzku7bp
25 Feb 19
IPO registration (amended)
3:30pm
S-1
zr976icm12f x1161v
29 Jan 19
IPO registration
12:00am
- Prev
- 1
- Next